Allen Loyd V
International Journal of Pharmaceutical Compounding.
Int J Pharm Compd. 2023 Jul-Aug;27(4):305-313.
Intravenous admixture compounding is common practice in most hospitals throughout the world, regardless of the country. Compounding intravenous medications medications involves risk as there is a high potential for error due to their complexity in compounding, and working in an aseptic environment itself poses issues for the compounder. Part 1 of this series presented an introduction and an overview of the series; part 2 presented parenteral vehicle considerations and examples; and part 3 discusses preparation procedures as well as discussions on standardization (both formulas and procedures), competency, compliance issues, issues with using commercial product additives, and look-alike drugs.
静脉药物混合配制在世界上大多数医院都是常见的做法，无论所在国家如何。配制静脉用药物存在风险，因为其配制过程复杂，出错可能性很大，而且在无菌环境中工作本身也给配制人员带来问题。本系列的第1部分介绍了该系列并给出了概述；第2部分介绍了肠外溶媒的注意事项及示例；第3部分讨论了配制程序以及关于标准化（包括配方和程序）、能力、合规问题、使用商业产品添加剂的问题以及相似药品的讨论。
